| Pos |
No. |
Sex |
Age |
Organ |
Pathology diagnosis |
Grade |
Stage |
TNM |
Type † |
|
A1 |
1 |
M |
61 |
Bladder |
Transitional cell carcinoma |
1 |
II |
T2N0M0 |
Malignant |
|
A2 |
2 |
F |
56 |
Bladder |
Transitional cell carcinoma |
1 |
II |
T2N0M0 |
Malignant |
|
A3 |
3 |
M |
52 |
Bladder |
Transitional cell carcinoma |
1 |
II |
T2N0M0 |
Malignant |
|
A4 |
4 |
M |
72 |
Bladder |
Transitional cell carcinoma |
1 |
II |
T2N0M0 |
Malignant |
|
A5 |
5 |
F |
25 |
Bladder |
Transitional cell carcinoma |
1 |
II |
T2N0M0 |
Malignant |
|
A6 |
6 |
M |
53 |
Bladder |
Transitional cell carcinoma |
1 |
II |
T2N0M0 |
Malignant |
|
A7 |
7 |
F |
79 |
Bladder |
Transitional cell carcinoma |
1 |
II |
T2N0M0 |
Malignant |
|
A8 |
8 |
M |
56 |
Bladder |
Transitional cell carcinoma |
1 |
II |
T2N0M0 |
Malignant |
|
B1 |
9 |
M |
66 |
Bladder |
Transitional cell carcinoma |
1 |
II |
T2N0M0 |
Malignant |
|
B2 |
10 |
M |
69 |
Bladder |
Transitional cell carcinoma |
1 |
II |
T2N0M0 |
Malignant |
|
B3 |
11 |
M |
48 |
Bladder |
Transitional cell carcinoma |
2 |
II |
T2N0M0 |
Malignant |
|
B4 |
12 |
M |
65 |
Bladder |
Transitional cell carcinoma (sparse) |
2 |
II |
T2N0M0 |
Malignant |
|
B5 |
13 |
M |
70 |
Bladder |
Transitional cell carcinoma |
2 |
II |
T2N0M0 |
Malignant |
|
B6 |
14 |
F |
64 |
Bladder |
Transitional cell carcinoma |
2 |
II |
T2N0M0 |
Malignant |
|
B7 |
15 |
M |
42 |
Bladder |
Transitional cell carcinoma |
2 |
II |
T2N0M0 |
Malignant |
|
B8 |
16 |
F |
48 |
Bladder |
Transitional cell carcinoma |
2 |
II |
T2N0M0 |
Malignant |
|
C1 |
17 |
M |
70 |
Bladder |
Transitional cell carcinoma |
1 |
II |
T2N0M0 |
Malignant |
|
C2 |
18 |
M |
70 |
Bladder |
Transitional cell carcinoma |
2 |
II |
T2N0M0 |
Malignant |
|
C3 |
19 |
M |
76 |
Bladder |
Transitional cell carcinoma |
2 |
II |
T3aN0M0 |
Malignant |
|
C4 |
20 |
M |
72 |
Bladder |
Transitional cell carcinoma |
2 |
II |
T3aN0M0 |
Malignant |
|
C5 |
21 |
M |
42 |
Bladder |
Transitional cell carcinoma |
2 |
II |
T2N0M0 |
Malignant |
|
C6 |
22 |
M |
69 |
Bladder |
Transitional cell carcinoma |
2 |
II |
T2N0M0 |
Malignant |
|
C7 |
23 |
F |
67 |
Bladder |
Transitional cell carcinoma |
2 |
II |
T2N0M0 |
Malignant |
|
C8 |
24 |
M |
70 |
Bladder |
Transitional cell carcinoma |
2 |
II |
T2N0M0 |
Malignant |
|
D1 |
25 |
M |
78 |
Bladder |
Transitional cell carcinoma |
2 |
II |
T2N0M0 |
Malignant |
|
D2 |
26 |
M |
71 |
Bladder |
Transitional cell carcinoma |
2 |
II |
T2aN0M0 |
Malignant |
|
D3 |
27 |
M |
65 |
Bladder |
Transitional cell carcinoma |
2 |
II |
T3aN0M0 |
Malignant |
|
D4 |
28 |
F |
50 |
Bladder |
Transitional cell carcinoma |
2 |
II |
T2N0M0 |
Malignant |
|
D5 |
29 |
M |
59 |
Bladder |
Transitional cell carcinoma |
2 |
II |
T2N0M0 |
Malignant |
|
D6 |
30 |
M |
45 |
Bladder |
Transitional cell carcinoma |
2 |
III |
T3bN0M0 |
Malignant |
|
D7 |
31 |
M |
42 |
Bladder |
Transitional cell carcinoma |
2 |
II |
T2aN0M0 |
Malignant |
|
D8 |
32 |
F |
70 |
Bladder |
Transitional cell carcinoma |
2 |
II |
T2N0M0 |
Malignant |
|
E1 |
33 |
F |
37 |
Bladder |
Transitional cell carcinoma |
2 |
II |
T2N0M0 |
Malignant |
|
E2 |
34 |
M |
44 |
Bladder |
Transitional cell carcinoma |
2 |
II |
T2N0M0 |
Malignant |
|
E3 |
35 |
M |
62 |
Bladder |
Transitional cell carcinoma |
2 |
II |
T2N0M0 |
Malignant |
|
E4 |
36 |
M |
60 |
Bladder |
Transitional cell carcinoma |
3 |
II |
T3aN0M0 |
Malignant |
|
E5 |
37 |
M |
55 |
Bladder |
Transitional cell carcinoma |
2 |
II |
T2N0M0 |
Malignant |
|
E6 |
38 |
M |
68 |
Bladder |
Transitional cell carcinoma |
3 |
II |
T2aN0M0 |
Malignant |
|
E7 |
39 |
M |
61 |
Bladder |
Transitional cell carcinoma |
3 |
II |
T2N0M0 |
Malignant |
|
E8 |
40 |
M |
64 |
Bladder |
Transitional cell carcinoma |
3 |
II |
T2N0M0 |
Malignant |
|
F1 |
41 |
M |
52 |
Bladder |
Transitional cell carcinoma |
3 |
II |
T2N0M0 |
Malignant |
|
F2 |
42 |
F |
61 |
Bladder |
Transitional cell carcinoma |
3 |
II |
T3N0M0 |
Malignant |
|
F3 |
43 |
F |
65 |
Bladder |
Transitional cell carcinoma |
3 |
II |
T3aN0M0 |
Malignant |
|
F4 |
44 |
M |
66 |
Bladder |
Transitional cell carcinoma |
3 |
III |
T3N0M0 |
Malignant |
|
F5 |
45 |
M |
65 |
Bladder |
Transitional cell carcinoma |
3 |
II |
T2N0M0 |
Malignant |
|
F6 |
46 |
M |
74 |
Bladder |
Transitional cell carcinoma |
3 |
II |
T2N0M0 |
Malignant |
|
F7 |
47 |
M |
52 |
Bladder |
Transitional cell carcinoma |
3 |
II |
T3N0M0 |
Malignant |
|
F8 |
48 |
M |
51 |
Bladder |
Transitional cell carcinoma |
3 |
II |
T2N0M0 |
Malignant |
|
–
|
– |
M |
58 |
Skin |
Malignant melanoma (tissue marker) |
– |
|
|
Malignant |
**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum